Tag: diagnostics industry
January 23, 2018
ChroMedX Appoints Dr. Richard Janeczko as Chief Commercial Officer; Jessica Kuhn as Chief Operations Officer
ChroMedX Corp. (CSE: CHX) (OTCQB: CHXIF) (FSE: EIY2) (the "Company"), developer of the HemoPalm Handheld Blood Analyzer System, is pleased...
January 3, 2018
ChroMedX Corp. Executes Definitive Agreement with DxEconomix to Lead Value-Based Transactions
ChroMedX Corp. (CSE:CHX) (OTC:CHXIF) (FSE: EIY2), (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to report... December 19, 2017
Co-Diagnostics Enters Into Lease for New Laboratory Facility
Co-Diagnostics announced the leasing of a new CGMP-ready and Biological Safety Level 2 laboratory facility in Salt Lake City.
December 13, 2017
ChroMedX Announces Exercise of Warrants
ChroMedX Corp. (CSE:CHX) (OTC: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
December 7, 2017
ChroMedX Strengthens Board of Directors with the Appointment of Dr. Richard Janeczko
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company”), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 27, 2017
ChroMedX Accepts Proposal; Signs LOI with Diagnostic Marketing Experts to Conduct a Value-Based Transaction for the HemoPalm Blood Analyzer System
ChroMedX Corp. (CSE:CHX) (OTCQB: CHXIF) (FSE: EIY2) (the “Company“), developer of the HemoPalm Handheld Blood Analyzer System, is pleased to...
November 24, 2017